Alnylam Pharmaceuticals, Inc. (ALNY) Reports Q4 Loss of $0.33
Tweet Send to a FriendGet Alerts ALNY Hot Sheet
Price: $30.09 +0.33%
Revenue Growth %: -9.7%
Financial Fact:
Loss from operations: -9.8M
Today's EPS Names:
ATU, CRWS, CLC, More
Revenue Growth %: -9.7%
Financial Fact:
Loss from operations: -9.8M
Today's EPS Names:
ATU, CRWS, CLC, More
Trade ALNY Now!
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) reported Q4 EPS of ($0.33), $0.01 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $20.5 million versus the consensus estimate of $20.9 million.
For earnings history and earnings-related data on Alnylam Pharmaceuticals, Inc. (ALNY) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Alnylam Pharmaceuticals, Inc. (ALNY) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Five Below (FIVE) Tops Q1 EPS by 1c, Boosts FY13 Outlook
- PVH Corp. (PVH) Tops Q1 EPS by 56c; Issues Q2 EPS, Revs Outlook
- La-Z-boy, Inc. (LZB) Tops Q4 EPS by 5c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
